269 related articles for article (PubMed ID: 32728730)
21. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
[TBL] [Abstract][Full Text] [Related]
22.
Fernandes M; Mari L; Chiaravalloti A; Paoli B; Nuccetelli M; Izzi F; Giambrone MP; Camedda R; Bernardini S; Schillaci O; Mercuri NB; Placidi F; Liguori C
J Neurol; 2022 Oct; 269(10):5356-5367. PubMed ID: 35608659
[TBL] [Abstract][Full Text] [Related]
23. The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimer's disease.
Li X; Li TQ; Andreasen N; Wiberg MK; Westman E; Wahlund LO
J Intern Med; 2014 Apr; 275(4):418-27. PubMed ID: 24237038
[TBL] [Abstract][Full Text] [Related]
24. Associations between self-reported sleep quality and cerebrospinal fluid biomarkers in mild cognitive impairment and Alzheimer's disease.
Durães J; Marques P; Novo AM; Facas J; Duro D; Lima M; Leitão MJ; Tábuas-Pereira M; Baldeiras I; Santana I
Rev Neurol (Paris); 2023 Oct; 179(8):877-881. PubMed ID: 36914478
[TBL] [Abstract][Full Text] [Related]
25. Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer's disease course.
Liguori C; Placidi F; Izzi F; Spanetta M; Mercuri NB; Di Pucchio A
Alzheimers Res Ther; 2020 Jan; 12(1):5. PubMed ID: 31901236
[TBL] [Abstract][Full Text] [Related]
26. Usefulness of CSF Biomarkers in Predicting the Progression of Amnesic and Nonamnesic Mild Cognitive Impairment to Alzheimer's Disease.
Ortega RL; Dakterzada F; Arias A; Blasco E; Naudí A; Garcia FP; Piñol-Ripoll G
Curr Aging Sci; 2019; 12(1):35-42. PubMed ID: 31589110
[TBL] [Abstract][Full Text] [Related]
27. Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid.
Rosenberg A; Solomon A; Jelic V; Hagman G; Bogdanovic N; Kivipelto M
Alzheimers Res Ther; 2019 Dec; 11(1):99. PubMed ID: 31805990
[TBL] [Abstract][Full Text] [Related]
28. Inflammation, tau pathology, and synaptic integrity associated with sleep spindles and memory prior to β-amyloid positivity.
Mander BA; Dave A; Lui KK; Sprecher KE; Berisha D; Chappel-Farley MG; Chen IY; Riedner BA; Heston M; Suridjan I; Kollmorgen G; Zetterberg H; Blennow K; Carlsson CM; Okonkwo OC; Asthana S; Johnson SC; Bendlin BB; Benca RM
Sleep; 2022 Sep; 45(9):. PubMed ID: 35670275
[TBL] [Abstract][Full Text] [Related]
29. Self-reported obstructive sleep apnea, amyloid and tau burden, and Alzheimer's disease time-dependent progression.
Bubu OM; Umasabor-Bubu OQ; Turner AD; Parekh A; Mullins AE; Kam K; Birckbichler MK; Mukhtar F; Mbah AK; Williams NJ; Rapoport DM; de Leon M; Jean-Louis G; Ayappa I; Varga AW; Osorio RS;
Alzheimers Dement; 2020 Oct; ():. PubMed ID: 33090679
[TBL] [Abstract][Full Text] [Related]
30. Concordance and Diagnostic Accuracy of [11C]PIB PET and Cerebrospinal Fluid Biomarkers in a Sample of Patients with Mild Cognitive Impairment and Alzheimer's Disease.
Leuzy A; Carter SF; Chiotis K; Almkvist O; Wall A; Nordberg A
J Alzheimers Dis; 2015; 45(4):1077-88. PubMed ID: 25649653
[TBL] [Abstract][Full Text] [Related]
31. Intermittent hypoxia and sleep disruption in obstructive sleep apnea increase serum tau and amyloid-beta levels.
Bhuniya S; Goyal M; Chowdhury N; Mishra P
J Sleep Res; 2022 Oct; 31(5):e13566. PubMed ID: 35165967
[TBL] [Abstract][Full Text] [Related]
32. A Longitudinal Study of Total and Phosphorylated α-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment.
Wang H; Stewart T; Toledo JB; Ginghina C; Tang L; Atik A; Aro P; Shaw LM; Trojanowski JQ; Galasko DR; Edland S; Jensen PH; Shi M; Zhang J;
J Alzheimers Dis; 2018; 61(4):1541-1553. PubMed ID: 29376878
[TBL] [Abstract][Full Text] [Related]
33. Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer's disease from other dementias and healthy controls in the OPTIMA cohort.
Seeburger JL; Holder DJ; Combrinck M; Joachim C; Laterza O; Tanen M; Dallob A; Chappell D; Snyder K; Flynn M; Simon A; Modur V; Potter WZ; Wilcock G; Savage MJ; Smith AD
J Alzheimers Dis; 2015; 44(2):525-39. PubMed ID: 25391385
[TBL] [Abstract][Full Text] [Related]
34. Obstructive Sleep Apnea and Its Treatment in Aging: Effects on Alzheimer's disease Biomarkers, Cognition, Brain Structure and Neurophysiology.
Mullins AE; Kam K; Parekh A; Bubu OM; Osorio RS; Varga AW
Neurobiol Dis; 2020 Nov; 145():105054. PubMed ID: 32860945
[TBL] [Abstract][Full Text] [Related]
35. Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease.
van Rossum IA; Visser PJ; Knol DL; van der Flier WM; Teunissen CE; Barkhof F; Blankenstein MA; Scheltens P
J Alzheimers Dis; 2012; 29(2):319-27. PubMed ID: 22233766
[TBL] [Abstract][Full Text] [Related]
36. Complement activation mainly mediates the association of heart rate variability and cognitive impairment in adults with obstructive sleep apnea without dementia.
Xue S; Li MF; Leng B; Yao R; Sun Z; Yang Y; Gao YL; Liu X; Sun HR; Li Z; Zhang J
Sleep; 2023 Feb; 46(2):. PubMed ID: 35766800
[TBL] [Abstract][Full Text] [Related]
37. Breathing cessation events that compose the apnea-hypopnea index are distinctively associated with the adverse outcomes in Alzheimer's disease.
Targa ADS; Benítez ID; Moncusí-Moix A; Dakterzada F; Minguez O; Vaca R; Dalmases M; Sanchez-de-la-Torre M; Barbé F; Piñol-Ripoll G
Alzheimers Res Ther; 2023 Jul; 15(1):123. PubMed ID: 37452339
[TBL] [Abstract][Full Text] [Related]
38. Cognitive impairment in remitted late-life depression is not associated with Alzheimer's disease-related CSF biomarkers.
Loureiro JC; Stella F; Pais MV; Radanovic M; Canineu PR; Joaquim HPG; Talib LL; Forlenza OV
J Affect Disord; 2020 Jul; 272():409-416. PubMed ID: 32553384
[TBL] [Abstract][Full Text] [Related]
39. A systematic review with meta-analysis to assess Alzheimer's disease biomarkers in adults with or without obstructive sleep apnoea.
Mohammadi I; Adibparsa M; Najafi A; Sehat MS; Sadeghi M
Int Orthod; 2023 Dec; 21(4):100814. PubMed ID: 37776696
[TBL] [Abstract][Full Text] [Related]
40. Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework.
Mattsson N; Lönneborg A; Boccardi M; Blennow K; Hansson O;
Neurobiol Aging; 2017 Apr; 52():196-213. PubMed ID: 28317649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
